Sensus Healthcare, Inc. SRTS
Medical/Dental Instruments · IPO 2016 · data as of November 13, 2026
Sensus Healthcare, Inc. (SRTS) is a healthcare company listed in the US with a market value of about $38M. In the twelve months to September 30, 2026 it had revenue of $17M and net income of -$16M, a net margin of -96.5%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 23% a year, a 5-year average ROIC of 6%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 10% below the current price.
About Sensus Healthcare
Sensus Healthcare is listed in the US and classified in medical/dental instruments, IPO year 2016. Revenue went from $10M in 2015 to $27M in 2025, growth of about 10.3% a year. It was profitable in 4 of the last 10 years in our data. It spends 28% of revenue on research and development.
Score: 1.2 / 5
Checks passed
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
- Share count down over 3 years (buybacks)
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17M | $27M | $42M | $24M | $45M | $27M | $10M | $27M | $26M | $21M | $15M |
| Net income | -$16M | -$8M | $7M | $485000 | $24M | $4M | -$7M | -$2M | -$2M | -$4M | -$346448 |
| Free cash flow | -$12M | $332000 | -$1M | -$2M | -$2M | -$414000 | -$793000 | -$3M | -$9M | -$3M | -$1M |
| EPS (diluted) | $-0.97 | $-0.47 | $0.41 | $0.03 | $1.46 | $0.25 | $-0.42 | $-0.10 | $-0.14 | $-0.28 | $-0.03 |
| Net margin | -96.5% | -28.1% | 15.9% | 2.0% | 54.4% | 15.2% | -71.4% | -6.2% | -7.6% | -18.0% | -2.3% |
| ROIC | — | -17.0% | 10.6% | -0.6% | 26.2% | 12.4% | -28.8% | -5.3% | -6.0% | -21.1% | -1.9% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 4 analysts is $5.38, 131% above the current price; targets range from $4.00 to $6.00; the consensus rating is “Strong buy”; expected EPS is $-0.81 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Sensus Healthcare stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 10% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Sensus Healthcare pay a dividend?
Not currently.
Is Sensus Healthcare a good stock to buy?
We do not give buy or sell advice. Sensus Healthcare scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.